Fund shareholders of ENVERIC BIOSCIENCES INC
ISIN US29405E5050 · United States · LEI 549300CATCWKUQ6G5854
- Fund shareholders
- 4
- Of which ETFs
- 1 3 other funds
- Value held
- 98.1K $
- Share of capital
- 1.4 % of 4.5M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 35,417 | 48.9K $ | 0.11 % | 0.79 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 14,912 | 20.6K $ | 0.33 % | as of Jun 30, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 11,555 | 26.6K $ | 0.00 % | 0.26 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 911 | 2.1K $ | 0.02 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 62,795 | +148.8 % |
| 2026Q2 | 4 | 0 | 25,241 | +30.7 % |
| 2026Q1 | 4 | 19,316 |
Institutional managers
11 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 32,149 | 62.4K $ | as of Mar 31, 2026 |
| AdvisorShares Investments LLC | 16,974 | 32.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 3,612 | 7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,103 | 2.1K $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 1,000 | 1.9K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 83 | 161 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 51 | 99 $ | as of Mar 31, 2026 |
| NATIONAL BANK OF CANADA /FI/ | 1 | 2 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 1 | 2 $ | as of Mar 31, 2026 |
| DANSKE BANK A/S | 1 | 2 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of ENVERIC BIOSCIENCES INC
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Armistice Capital, LLC and 1 other | 9.99 % | 405,092 | as of Jun 30, 2026 · SCHEDULE 13G |
| Ayrton Capital LLC and 2 others | 2.93 % | 111,145 | as of Jun 30, 2026 · SCHEDULE 13G |
| Lind Global Fund III LP and 2 others | 1.40 % | 51,866 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ENVERIC BIOSCIENCES INC". https://titelia.com/en/stocks/enveric-biosciences-inc-US29405E5050